Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury. | Exp Mol Med | 2022 | 34997212 | PubTator, text mining | PubMed |
| Predicting the targets of IRF8 and NFATc1 during osteoclast differentiation using the machine learning method framework cTAP. | BMC Genomics | 2022 | 34991467 | PubTator, text mining | PubMed |
| PIP3 abundance overcomes PI3K signaling selectivity in invadopodia. | FEBS Lett | 2022 | 34990021 | PubTator, text mining | PubMed |
| Compression enhances invasive phenotype and matrix degradation of breast Cancer cells via Piezo1 activation. | BMC Mol Cell Biol | 2022 | 34979904 | PubTator, text mining | PubMed |
| Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1. | Cancer Sci | 2022 | 34962019 | PubTator, text mining | PubMed |
| StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42. | Eur J Cell Biol | 2022 | 34958986 | PubTator, text mining | PubMed |
| Data on the effects of ECM rigidity on actomyosin contractility and invadopodia activity in individual versus pairs of head and neck squamous cell carcinoma cells. | Data Brief | 2022 | 34950756 | PubTator, text mining | PubMed |
| Cell-extracellular matrix dynamics. | Phys Biol | 2022 | 34911051 | PubTator, text mining | PubMed |
| The double-edged sword effect of HDAC6 in Aβ toxicities. | FASEB J | 2022 | 34907598 | PubTator, text mining | PubMed |
| Combined Quantitative (Phospho)proteomics and Mass Spectrometry Imaging Reveal Temporal and Spatial Protein Changes in Human Intestinal Ischemia-Reperfusion. | J Proteome Res | 2022 | 34874173 | PubTator, text mining | PubMed |
| Nucleation, stabilization, and disassembly of branched actin networks. | Trends Cell Biol | 2022 | 34836783 | PubTator, text mining | PubMed |
| Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors. | J Clin Endocrinol Metab | 2022 | 34791326 | PubTator, text mining | PubMed |
| Impact of Collagen Triple Helix Structure on Melanoma Cell Invadopodia Formation and Matrix Degradation upon BRAF Inhibitor Treatment. | Adv Healthc Mater | 2022 | 34783464 | PubTator, text mining | PubMed |
| Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases. | J Leukoc Biol | 2022 | 34755380 | PubTator, text mining | PubMed |
| The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs). | Transl Oncol | 2022 | 34678587 | PubTator, text mining | PubMed |
| Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease. | Cardiovasc Toxicol | 2022 | 34669097 | PubTator, text mining | PubMed |
| Cortactin and HER2 as potential markers for dural-targeted therapy in advanced gastric cancer. | Clin Exp Med | 2022 | 34533670 | PubTator, text mining | PubMed |
| Desmosomal Cadherins in Health and Disease. | Annu Rev Pathol | 2022 | 34425055 | PubTator, text mining | PubMed |
| Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. | Arthritis Rheumatol | 2022 | 34313394 | PubTator, text mining | PubMed |
| Human neuromuscular junction three-dimensional organoid models and the insight in motor disorders. | J Mol Cell Biol | 2022 | 34270721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=42